➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Boehringer Ingelheim
Harvard Business School
Moodys
AstraZeneca

Last Updated: January 17, 2021

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc. (N.D. Cal. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Takeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc. (N.D. Cal. 2011)

Docket   Start Trial Date Filed 2011-04-01
Court District Court, N.D. California Date Terminated 2013-11-01
Cause 35:271 Patent Infringement Assigned To Joseph C. Spero
Jury Demand None Referred To Jacqueline Scott Corley
Parties HANDA PHARMACEUTICALS, LLC; IMPAX LABORATORIES, INC.; IMPAX LABORATORIES, INC.,; PAR PHARMACEUTICAL, INC.; SANDOZ INC.; TAKEDA PHARMACEUTICAL CO., LTD.; TAKEDA PHARMACEUTICALS AMERICA, INC.; TAKEDA PHARMACEUTICALS LLC; TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.
Patents 6,162,463; 6,228,398; 6,462,058; 6,664,276; 6,939,971; 7,285,668; 7,790,755
Attorneys Brian Francis McMahon; David C. Doyle; Edward George Dane; Eric Martin Acker; Erin Joan Cox; Heather E. Takahashi; Jeffrey I. Weinberger; Jessica E. La Londe; Joel Matthew Purles; Marc Dana Sharp; Mark T. Jansen; Parisa Jorjani; Pilar Stillwater; Ryan Neil Hagglund; Ted G. Dane , Esq.; Tina Wang Arroyo
Firms Christensen O'Connor Johnson Kindness PLLC; Crowell and Moring LLP; Morrison & Foerster LLP; Morrison and Foerster; Munger Tolles & Olson LLP; Munger Tolles Olson LLP; Munger, Tolles & Olson LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Takeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Takeda Pharmaceutical Co., Ltd. v. Impax Laboratories, Inc. (N.D. Cal. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-04-01 1 6,162,463 A 1212000 Lippa (73) Assignee: …U.S. Patent No. 6,462,058 (the “’058 12 Patent”), U.S. Patent No. 6,664,276 (the “’276 Patent”), U.…U.S. Patent No. 6,939,971 (the “’971 13 Patent”), U.S. Patent No. 7,285,668 (the “’668 Patent”), and…and U.S. Patent No. 7,790,755 (the “’755 14 Patent”) (collectively, the “Asserted Patents”). 15 …3 A. Asserted Patents 4 1. The ’058 Patent 5 13. On October External link to document
2013-05-28 305 of U.S. Patent No. 6,462,058 (the '''058 patent"); U.S. Patent No. 6,664,276… TX0001 U.S. Patent No.6,462,058 …Extrinsic Evidence for U.S. Patent No. 6,462,058 TX0064x03 The United States Pharmacopeia…TX0064x07 Prosecution History for U.S. Patent No. 6,462,058, Original Claims DEX0001343 …TX0064x08 Prosecution History for U.S. Patent No. 6,462,058, Office Action DEX0001579 External link to document
2013-05-30 308 infringe U.S. Patent No. 6,462,058 ("the '058 23 Patent"), U.S. Patent No. 6,… 24 Patent") and U.S. Patent No. 7,790,755 ("the '75 5 Patent") (collectively…6,664,276 ("the '276 Patent"), U.S. Patent No. 6,939,971 ("the '971 …infringed U.S. Patent No. 27 7,285,668 ("the '668 Patent").…based on the '668 Patent, as well as Impax's counterclaims based on that patent, pursuant External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Moodys
Dow
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.